Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Aethlon Medical (AEMD) Net Margin (2016 - 2023)

Aethlon Medical filings provide 13 years of Net Margin readings, the most recent being 429.6% for Q1 2023.

  • On a quarterly basis, Net Margin rose 2843361.0% to 429.6% in Q1 2023 year-over-year; TTM through Mar 2023 was 1953.9%, a 158787.0% increase, with the full-year FY2023 number at 2070.14%, up 147239.0% from a year prior.
  • Net Margin hit 429.6% in Q1 2023 for Aethlon Medical, up from 28863.21% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 198.55% in Q4 2019 to a low of 28863.21% in Q1 2022.
  • Median Net Margin over the past 5 years was 1590.14% (2021), compared with a mean of 5834.36%.
  • Biggest five-year swings in Net Margin: tumbled -2224788bps in 2022 and later surged 2843361bps in 2023.
  • Aethlon Medical's Net Margin stood at 198.55% in 2019, then crashed by -97bps to 391.18% in 2020, then tumbled by -3672bps to 14755.69% in 2021, then plummeted by -96bps to 28863.21% in 2022, then surged by 99bps to 429.6% in 2023.
  • The last three reported values for Net Margin were 429.6% (Q1 2023), 28863.21% (Q1 2022), and 14755.69% (Q4 2021) per Business Quant data.